Beauvericin ameliorates experimental colitis by inhibiting activated T cells via downregulation of the PI3K/Akt signaling pathway (Q28536748)

From Wikidata
Jump to navigation Jump to search
scientific article (publication date: 2013)
edit
Language Label Description Also known as
English
Beauvericin ameliorates experimental colitis by inhibiting activated T cells via downregulation of the PI3K/Akt signaling pathway
scientific article (publication date: 2013)

    Statements

    Beauvericin ameliorates experimental colitis by inhibiting activated T cells via downregulation of the PI3K/Akt signaling pathway (English)
    0 references
    Xue-Feng Wu
    0 references
    Rui Xu
    0 references
    Zi-Jun Ouyang
    0 references
    Cheng Qian
    0 references
    Yan Shen
    0 references
    Xu-Dong Wu
    0 references
    Yan-Hong Gu
    0 references
    Qiang Xu
    0 references
    Yang Sun
    0 references
    2013
    0 references
    0 references
    8
    0 references
    12
    0 references
    e83013
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit